Ovarian Cancer: Bevacizumab as Adjuvant Treatment—Not Yet

被引：0
|
作者：
Amit Agarwal
机构：
[1] B L Kapoor Memorial Hospital,
来源：
Indian Journal of Gynecologic Oncology | 2017年 / 15卷 / Suppl 1期
关键词：
Bevacizumab (BEV); High-risk Ovarian Cancer; Post-progression Treatment; Significant Residual Disease; Improved Progression Free Survival;
D O I：
10.1007/s40944-017-0165-6
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 10
页数：1
相关论文
共 50 条
  • [1] Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the US Medicare system
    Walter, A.
    Geisler, J.
    Manahan, K.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S110 - S111
  • [2] Annual cost of bevacizumab in the adjuvant treatment of ovarian cancer to the US Medicare system
    Walter, A.
    Manahan, K.
    Labarge, D.
    Phibbs, G.
    Geisler, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S15 - S15
  • [3] Bevacizumab in the treatment of ovarian cancer
    Han, Ernest S.
    Monk, Bradley J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (10) : 1339 - 1345
  • [4] Bevacizumab in the Treatment of Ovarian Cancer
    Florian Heitz
    Philipp Harter
    Jana Barinoff
    Bianca Beutel
    Paevi Kannisto
    Jacek P. Grabowski
    Julia Heitz
    Christian Kurzeder
    Andreas du Bois
    Advances in Therapy, 2012, 29 : 723 - 735
  • [5] Bevacizumab in the treatment of ovarian cancer
    Eskander, Ramez N.
    Randall, Leslie M.
    BIOLOGICS-TARGETS & THERAPY, 2011, 5 : 1 - 5
  • [6] Bevacizumab in the Treatment of Ovarian Cancer
    Heitz, Florian
    Harter, Philipp
    Barinoff, Jana
    Beutel, Bianca
    Kannisto, Paevi
    Grabowski, Jacek P.
    Heitz, Julia
    Kurzeder, Christian
    du Bois, Andreas
    ADVANCES IN THERAPY, 2012, 29 (09) : 723 - 735
  • [7] Bevacizumab in the Treatment of Metastatic Breast Cancer Bevacizumab in Breast Cancer: The Best Is Yet to Come?
    Traina, Tiffany A.
    ONCOLOGY-NEW YORK, 2009, 23 (04): : 327 - 332
  • [8] IMPACT OF ADJUVANT BEVACIZUMAB ON LYMPHOCELES AND SURVIVAL IN ADVANCED OVARIAN CANCER
    Perrin, M.
    Bentivegna, E.
    Bonneau, C.
    Uzan, C.
    Leary, A.
    Pautier, P.
    Genestie, C.
    Morice, P.
    Gouy, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 527 - 527
  • [9] Evaluation of Bevacizumab in the Adjuvant Treatment of Colon Cancer
    Saltz, Leonard
    CURRENT COLORECTAL CANCER REPORTS, 2010, 6 (03) : 109 - 110
  • [10] Tailored treatment for ovarian cancer: are we there yet?
    Cristiana Sessa
    Gianluca Del Conte
    Nature Reviews Clinical Oncology, 2010, 7 : 80 - 82
12345